Activation of phosphatidylinositol 3-kinase is important for erythropoietin-induced erythropoiesis from CD34+ hematopoietic progenitor cells

Experimental Hematology

Volumn 30, Issue 9, 2002, Pages 990-1000

  Myklebust, June Helen ^a   Blomhoff, Heidi Kiil ^b   Rusten, Leiv Sindre ^a   Stokke, Trond ^a   Smeland, Erlend B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; CD34 ANTIGEN; CD45 ANTIGEN; CD71 ANTIGEN; ENZYME INHIBITOR; ERYTHROPOIETIN; ERYTHROPOIETIN RECEPTOR; GLYCOPHORIN A; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE; PROTEIN KINASE B; PROTEIN KINASE C; STAT PROTEIN; SYNAPTOPHYSIN;

APOPTOSIS; ARTICLE; CELL CYCLE; CELL DIVISION; CELL MATURATION; CELL PROLIFERATION; CELL SELECTION; CELL SUBPOPULATION; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME ASSAY; ERYTHROID CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL; TIME; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADULT; ANTIGENS, CD34; ANTIGENS, DIFFERENTIATION; BUTADIENES; CARBAZOLES; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; CHROMONES; ENZYME ACTIVATION; ENZYME INHIBITORS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; ERYTHROPOIETIN; FLAVONOIDS; GLYCOPHORIN; HEMATOPOIETIC STEM CELLS; HUMANS; INDOLES; ISOENZYMES; MORPHOLINES; NAPHTHALENES; NITRILES; PROTEIN KINASE C; PROTEIN KINASE C-ALPHA; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RECOMBINANT PROTEINS; STAUROSPORINE; STEM CELL FACTOR;

EID: 0036754036     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-472X(02)00868-8     Document Type: Article

References (58)

1. Krantz S.B. Erythropoietin. Blood. 77:1991;419.
2. Livnah O., Stura E.A., Middleton S.A., Johnson D.L., Jolliffe L.K., Wilson I.A. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science. 283:1999;987.
3. Remy I., Wilson I.A., Michnick S.W. Erythropoietin receptor activation by a ligand-induced conformation change. Science. 283:1999;990.
4. Witthuhn B.A., Quelle F.W., Silvennoinen O.et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell. 74:1993;227.
5. Miura O., Nakamura N., Quelle F.W., Witthuhn B.A., Ihle J.N., Aoki N. Erythropoietin induces association of the JAK2 protein tyrosine kinase with the erythropoietin receptor in vivo. Blood. 84:1994;1501.
6. Bittorf T., Jaster R., Ludtke B., Kamper B., Brock J. Requirement for JAK2 in erythropoietin-induced signalling pathways. Cell Signal. 9:1997;85.
7. Damen J.E., Krystal G. Early events in erythropoietin-induced signaling. Exp Hematol. 24:1996;1455.
8. Damen J.E., Wakao H., Miyajima A.et al. Tyrosine 343 in the erythropoietin receptor positively regulates erythropoietin-induced cell proliferation and Stat5 activation. EMBO J. 14:1995;5557.
9. Quelle F.W., Wang D., Nosaka T.et al. Erythropoietin induces activation of Stat5 through association with specific tyrosines on the receptor that are not required for a mitogenic response. Mol Cell Biol. 16:1996;1622.
10. Damen J.E., Cutler R.L., Jiao H., Yi T., Krystal G. Phosphorylation of tyrosine 503 in the erythropoietin receptor (EpR) is essential for binding the P85 subunit of phosphatidylinositol (PI) 3-kinase and for EpR-associated PI 3-kinase activity. J Biol Chem. 270:1995;23402.
11. He T.C., Zhuang H., Jiang N., Waterfield M.D., Wojchowski D.M. Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. Blood. 82:1993;3530.
12. Damen J.E., Liu L., Cutler R.L., Krystal G. Erythropoietin stimulates the tyrosine phosphorylation of Shc and its association with Grb2 and a 145-Kd tyrosine phosphorylated protein. Blood. 82:1993;2296.
13. Yi T., Zhang J., Miura O., Ihle J.N. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation. identification of potential binding sites Blood. 85:1995;87.
14. Klingmuller U., Lorenz U., Cantley L.C., Neel B.G., Lodish H.F. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell. 80:1995;729.
15. Lecoq-Lafon C., Verdier F., Fichelson S.et al. Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Blood. 93:1999;2578.
16. Boulton T.G., Nye S.H., Robbins D.J.et al. Erks. a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and ngf Cell. 65:1991;663.
17. Seger R., Krebs E.G. The MAPK signaling cascade. FASEB J. 9:1995;726.
18. Minden A., Karin M. Regulation and function of the JNK subgroup of MAP kinases. Biochim Biophys Acta. 1333:1997;F85.
19. Ichijo H. From receptors to stress-activated MAP kinases. Oncogene. 18:1999;6087.
20. Zhou G., Bao Z.Q., Dixon J.E. Components of a new human protein kinase signal transduction pathway. J Biol Chem. 270:1995;12665.
21. Nishigaki K., Hanson C., Ohashi T., Thompson D., Muszynski K., Ruscetti S. Erythroid cells rendered erythropoietin independent by infection with Friend spleen focus-forming virus show constitutive activation of phosphatidylinositol 3-kinase and Akt kinase. involvement of insulin receptor substrate-related adapter proteins J Virol. 74:2000;3037.
22. Nagata Y., Takahashi N., Davis R.J., Todokoro K. Activation of p38 MAP kinase and JNK but not ERK is required for erythropoietin-induced erythroid differentiation. Blood. 92:1998;1859.
23. Matsuzaki T., Aisaki K., Yamamura Y., Noda M., Ikawa Y. Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a friend murine leukemia cell line. Oncogene. 19:2000;1500.
24. Nagata Y., Nishida E., Todokoro K. Activation of JNK signaling pathway by erythropoietin, thrombopoietin, and interleukin-3. Blood. 89:1997;2664.
25. Nagata Y., Moriguchi T., Nishida E., Todokoro K. Activation of p38 MAP kinase pathway by erythropoietin and interleukin-3. Blood. 90:1997;929.
26. Kubota Y., Tanaka T., Yamaoka G.et al. Wortmannin, a specific inhibitor of phosphatidylinositol-3-kinase, inhibits erythropoietin-induced erythroid differentiation of K562 cells. Leukemia. 10:1996;720.
27. Shigematsu H., Iwasaki H., Otsuka T., Ohno Y., Arima F., Niho Y. Role of the vav proto-oncogene product (Vav) in erythropoietin-mediated cell proliferation and phosphatidylinositol 3-kinase activity. J Biol Chem. 272:1997;14334.
28. Zochodne B., Truong A.H., Stetler K.et al. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways. implication for erythropoiesis and Friend virus-induced erythroleukemia Oncogene. 19:2000;2296.
29. Uddin S., Kottegoda S., Stigger D., Platanias L.C., Wickrema A. Activation of the Akt/FKHRL1 pathway mediates the antiapoptotic effects of erythropoietin in primary human erythroid progenitors. Biochem Biophys Res Commun. 275:2000;16.
30. Kashii Y., Uchida M., Kirito K.et al. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood. 96:2000;941.
31. Klingmuller U., Wu H., Hsiao J.G.et al. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci U S A. 94:1997;3016.
32. Smeland E.B., Funderud S., Kvalheim G.et al. Isolation and characterization of human hematopoietic progenitor cells. an effective method for positive selection of CD34+ cells Leukemia. 6:1992;845.
33. Myklebust J.H., Smeland E.B., Josefsen D., Sioud M. Protein kinase C-α isoform is involved in erythropoietin-induced erythroid differentiation of CD34(+) progenitor cells from human bone marrow. Blood. 95:2000;510.
34. Bryder D., Jacobsen S.E. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood. 96:2000;1748.
35. Lyons A.B. Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J Immunol Methods. 243:2000;147.
36. Myklebust J.H., Josefsen D., Blomhoff H.K.et al. Activation of the cAMP signaling pathway increases apoptosis in human B-precursor cells and is associated with downregulation of Mcl-1 expression. J Cell Physiol. 180:1999;71.
37. - hematopoietic progenitor cells by suppressing apoptosis. Exp Hematol. 27:1999;1451.
38. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J Biol Chem. 269:1994;5241.
39. Bao H., Jacobs-Helber S.M., Lawson A.E., Penta K., Wickrema A., Sawyer S.T. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells). Blood. 93:1999;3757.
40. Mayani H., Dragowska W., Lansdorp P.M. Cytokine-induced selective expansion and maturation of erythroid versus myeloid progenitors from purified cord blood precursor cells. Blood. 81:1993;3252.
41. Loken M.R., Civin C.I., Bigbee W.L., Langlois R.G., Jensen R.H. Coordinate glycosylation and cell surface expression of glycophorin A during normal human erythropoiesis. Blood. 70:1987;1959.
42. Wu H., Klingmuller U., Besmer P., Lodish H.F. Interaction of the erythropoietin and stem-cell-factor receptors. Nature. 377:1995;242.
43. Panzenbock B., Bartunek P., Mapara M.Y., Zenke M. Growth and differentiation of human stem cell factor/erythropoietin-dependent erythroid progenitor cells in vitro. Blood. 92:1998;3658.
44. Josefsen D., Myklebust J.H., Lomo J., Sioud M., Blomhoff H.K., Smeland E.B. Differential expression of bcl-2 homologs in human CD34(+) hematopoietic progenitor cells induced to differentiate into erythroid or granulocytic cells. Stem Cells. 18:2000;261.
45. Wu H., Liu X., Jaenisch R., Lodish H.F. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell. 83:1995;59.
46. Nocka K., Majumder S., Chabot B., Ray P., Cervone M., Bernstein A., Besmer P. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice - evidence for an impaired c-kit kinase in mutant mice. Genes Dev. 3:1989;816.
47. Haseyama Y., Sawada K., Oda A.et al. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood. 94:1999;1568.
48. Kuo M.L., Chuang S.E., Lin M.T., Yang S.Y. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene. 20:2001;677.
49. Wang J.M., Chao J.R., Chen W., Kuo M.L., Yen J.J., Yang-Yen H.F. The antiapoptotic gene mcl-1 is up-regulated by the phosphatidylinositol 3-kinase/Akt signaling pathway through a transcription factor complex containing CREB. Mol Cell Biol. 19:1999;6195.
50. Bavelloni A., Faenza I., Aluigi M., Ferri A., Toker A., Maraldi N.M., Marmiroli S. Inhibition of phosphoinositide 3-kinase impairs pre-commitment cell cycle traverse and prevents differentiation in erythroleukaemia cells. Cell Death Differ. 7:2000;112.
51. Klippel A., Escobedo M.A., Wachowicz M.S.et al. Activation of phosphatidylinositol 3-kinase is sufficient for cell cycle entry and promotes cellular changes characteristic of oncogenic transformation. Mol Cell Biol. 18:1998;5699.
52. Muise-Helmericks R.C., Grimes H.L., Bellacosa A., Malstrom S.E., Tsichlis P.N., Rosen N. Cyclin D expression is controlled post-transcriptionally via a phosphatidylinositol 3-kinase/Akt-dependent pathway. J Biol Chem. 273:1998;29864.
53. Takuwa N., Fukui Y., Takuwa Y. Cyclin D1 expression mediated by phosphatidylinositol 3-kinase through mTOR-p70(S6K)-independent signaling in growth factor-stimulated NIH 3T3 fibroblasts. Mol Cell Biol. 19:1999;1346.
54. Phillips-Mason P.J., Raben D.M., Baldassare J.J. Phosphatidylinositol 3-kinase activity regulates α-thrombin-stimulated G1 progression by its effect on cyclin D1 expression and cyclin-dependent kinase 4 activity. J Biol Chem. 275:2000;18046.
55. Dijkers P.F., Medema R.H., Pals C.et al. Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol. 20:2000;9138.
56. Toyoshima H., Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell. 78:1994;67.
57. Kubota Y., Tanaka T., Kitanaka A.et al. Src transduces erythropoietin-induced differentiation signals through phosphatidylinositol 3-kinase. EMBO J. 20:2001;5666.
58. von Lindern M., Amelsvoort M.P., van Dijk T.et al. Protein kinase C alpha controls erythropoietin receptor signaling. J Biol Chem. 275:2000;34719.